Convano Inc.
【Convano】Executive Changes and Revamp of Mid-Term Management Plan｜May 2026
Convano Corporation will implement executive personnel changes at the Annual General Meeting of Shareholders scheduled for June 27, 2026, and has approved the transition to a new management structure. The company clarifies the management responsibility of the outgoing director Mr. Yo Toudai and invites Mr. Yusuke Funakoshi as a new candidate. The company aims to execute the mid-term management plan and enhance corporate value.
Key Figures
- Retiring Executive: Mr. Yo Toudai (retiring June 27, 2026)
- New Executive: Mr. Yusuke Funakoshi (assuming position June 27, 2026)
- Total Executives: 5 persons (1 new, 4 reappointed)
AI要約
Executive Changes and Management Restructuring
Convano Corporation will conduct executive personnel changes at the 13th Annual General Meeting of Shareholders scheduled for June 27, 2026. Outgoing director Mr. Yo Toudai voluntarily resigned to clarify his management responsibility related to valuation losses on cryptocurrency assets. Mr. Yusuke Funakoshi will be appointed as a director to expand the healthcare platform business and advance the mid-term management plan. This demonstrates the company's commitment to improving its medium- to long-term corporate value.
Future Management Policy and Shareholder Impact
The executive personnel changes aim to implement the new mid-term management plan and enhance corporate value, which is expected to lead to stable management and clearer growth strategies for shareholders. Mr. Yusuke Funakoshi, the new candidate, has extensive experience in the medical field and is expected to contribute to the group's business expansion. With the new management structure, expectations for future business development and growth strategies are rising.
Convano Corporation
Company overview · Stock price · Financial data · All IR
